Days At A Glance Speakers Session Type Search
Type

    08:50 - 09:00 
    Welcome and Introduction
    Chair: Anitha Kumaran (Southampton, UK)
    09:00 - 10:15 
    CME Session 1
    Chair: Anitha Kumaran (Southampton, UK) and James Law (Nottingham, UK)
    CME Session 1
    Epidemiology of adrenal crisis in children
    Sydney Clinical School, University of Notre Dame Australia, Sydney, Australia
    CME Session 1
    Kidney speaks - Interpreting kidney function tests in disorders of salt and water balance
    Leuven, Belgium
    CME Session 1
    Q&A
    10:15 - 10:45 
    CME Case Presentations 1
    Chair: Anitha Kumaran (Southampton, UK) and James Law (Nottingham, UK)
    OC1.1
    CME Case Presentations 1
    Severe hypercalcaemia in Williams-Beuren syndrome
    RBHSC, Belfast, UK
    OC1.2
    CME Case Presentations 1
    Two cases of functioning adrenocortical tumours secondary to TP53 variants
    London, UK
    CME Case Presentations 1
    Q&A
    10:45 - 11:00 
    Break
    11:00 - 12:15 
    CME Session 2
    Chair: Anitha Kumaran (Southampton, UK) and Charlotte Elder (Sheffield, UK)
    CME Session 2
    Update in the recognition and management of adolescent PCOS
    Sant Joan de Déu Hospital Barcelona, Barcelona, Spain
    CME Session 2
    Approach to a viralising girl in puberty
    Karolinska University Hospital, Stockholm, Sweden
    CME Session 2
    Q&A
    12:15 - 12:45 
    CME Case Presentations 2
    Chair: Anitha Kumaran (Southampton, UK) and Charlotte Elder (Sheffield, UK)
    OC2.1
    CME Case Presentations 2
    Pitfalls and challenges in the diagnosis and management of Cushing’s disease in children: An interesting case
    Sheffield, UK
    OC2.2
    CME Case Presentations 2
    Two cases of McCune-Albright Syndrome with multisystem involvement
    Alder Hey Children's Hospital, Liverpool, UK
    CME Case Presentations 2
    Q&A
    12:45 - 12:55 
    CSAC Trainee Representative
    12:55 - 13:55 
    Lunch
    13:55 - 15:10 
    CME Session 3
    Chair: Anitha Kumaran (Southampton, UK) and Senthil Senniappan (Liverpool, UK)
    CME Session 3
    Controversies in management of neonatal hypoglycaemia
    Texas, USA
    CME Session 3
    Hypothalamic obesity post cancer treatment - optimising outcomes
    San Francisco, USA
    CME Session 3
    Q&A
    15:10 - 15:15 
    CME Case Presentations 3
    Chair: Anitha Kumaran (Southampton, UK) and Senthil Senniappan (Liverpool, UK)
    OC3.1
    CME Case Presentations 3
    Rapid-Onset Obesity, Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation Syndrome (ROHHAD-NET): Case series & learning points
    Bristol, UK
    OC3.2
    CME Case Presentations 3
    Variable responses to sulfonylurea treatment in siblings from the same family with monogenic diabetes due to HNF1A mutation
    Department of Paediatric Endocrinology, Bristol Children's Hospital, Bristol, UK
    CME Case Presentations 3
    Q&A
    15:25 - 15:40 
    Break
    15:40 - 16:40 
    CME Session 4
    Chair: Anitha Kumaran (Southampton, UK) and Dr Sophia Sakka (London, UK)
    CME Session 4
    Updating Diabetes care with advances in diabetes technology and digital health
    University of Ljublijana, Ljubljana, Slovenia
    CME Session 4
    Hypoglycemia unawareness in type 1 diabetes – lessons learnt
    University of Dundee, Dundee, UK
    CME Session 4
    Q&A
    16:40 - 16:55 
    CME Officer's Update

    07:45 - 08:45 
    Industry Sponsored Satellite Symposium
    08:45 - 09:00 
    Break
    09:00 - 09:10 
    Welcome from BSPED President and Chair
    Chairs: Tabitha Randell (Nottingham, UK) & Senthil Senniappan (Liverpool, UK)
    09:10 - 10:40 
    Endocrine Oral Comms 1
    Chair: Hoong-Wei Gan (London, UK) and Justin Davies (Southampton, UK)
    OC4.1
    Endocrine Oral Comms 1
    Dominant Mutations in CCDC141 are found by Whole Exome Sequencing to be a Common Cause of Self-Limited Delayed Puberty
    London, UK
    OC4.2
    Endocrine Oral Comms 1
    Pseudohypoparathyroidism type 1A and 1B: presentation, phenotypes and phenotype-genotype associations
    North Middlesex Hospital, London, UK
    OC4.3
    Endocrine Oral Comms 1
    Growth hormone receptor 6Ω pseudoexon activation: a novel cause of severe growth hormone insensitivity
    London, UK
    OC4.4
    Endocrine Oral Comms 1
    Does Inflammation Underpin Polycystic Ovary Syndrome (PCOS)? A Proteomic Approach to Novel Non-Invasive Biomarker and Pathway Discovery in Adolescent PCOS
    London, UK
    Endocrine Oral Comms 1
    Q&A
    OC4.5
    Endocrine Oral Comms 1
    The biochemical evaluation of Metabolic Bone Disease of Prematurity (MBDP) in a high-risk population
    Queen Alexandra Hospital, Portsmouth, UK
    OC4.6
    Endocrine Oral Comms 1
    The management of adrenal cell carcinoma in the United Kingdom at a single centre: a 25 year experience
    London, UK
    OC4.7
    Endocrine Oral Comms 1
    The use of urinary steroid profiles in monitoring therapy in children with 21-hydroxylase deficiency – results from the CAH-UK cohort study
    Sheffield, UK
    OC4.8
    Endocrine Oral Comms 1
    Destination outcome of 1151 gender variant young people presenting to paediatric endocrinology clinics in England and Wales since 2008
    London, UK
    OC4.9
    Endocrine Oral Comms 1
    The use of Liraglutide in the treatment of childhood obesity
    Alder Hey Children's Hospital, Liverpool, UK
    Endocrine Oral Comms 1
    Q&A
    09:10 - 10:40 
    Diabetes Symposium 1
    Chair: Tabitha Randell (Nottingham, UK) and Amanda Peacock (Leeds, UK)
    Diabetes Symposium 1
    Low carbohydrate diets in type 1 diabetes
    Leeds Children’s Hospital, Leeds, UK
    Diabetes Symposium 1
    Eating disorder risk in weight management
    University of Sydney, Sydney, Australia
    Diabetes Symposium 1
    Low carbohydrate diets in type 2 diabetes
    RCGP Clinical Expert in Diabetes, Southport, UK
    Diabetes Symposium 1
    Q&A
    10:40 - 10:55 
    Break
    10:55 - 11:55 
    Endocrine Symposium 1
    Chair: Guftar Shaikh (Glasgow, UK) and Senthil Senniappan (Liverpool, UK)
    Endocrine Symposium 1
    Fertility preservation in boys
    Edinburgh, UK
    Endocrine Symposium 1
    Turner syndrome adolescence and beyond
    Medical Associates, Belfast, Ireland
    Endocrine Symposium 1
    Q&A
    10:55 - 11:55 
    Diabetes Symposium 2
    Chair: Noina Abid (Belfast, Northern Ireland) and Neil Wright (Sheffield, UK)
    Diabetes Symposium 2
    Controversies in the management of DKA
    Sheffield Children's NHS Foundation Trust, Sheffield, UK
    Diabetes Symposium 2
    Type 1 diabetes: moving into adulthood
    Portsmouth Hospital, Portsmouth, UK
    Diabetes Symposium 2
    Q&A
    11:55 - 12:25 
    Endocrine Oral Comms 2
    Chair: Renuka Dias (Birmingham, UK) and Pooja Sachdev (Nottingham, UK)
    OC5.1
    Endocrine Oral Comms 2
    Evaluating UK Referral Criteria for Children with Short Stature in a Tertiary Paediatric Endocrinology Centre
    London, UK
    OC5.2
    Endocrine Oral Comms 2
    Evaluation of the discrepancy between free thyroxine (FT4) reference ranges and the impact on clinical investigation of central hypothyroidism
    Maidstone, UK
    Maidstone, UK
    OC5.3
    Endocrine Oral Comms 2
    An Investigation Of Androgen-responsive Non-coding RNAs In Boys With Atypical Genitalia Without Genetic Variants in the Androgen Receptor (AR)
    Glasgow, UK
    OC5.4
    Endocrine Oral Comms 2
    Virtual exercise sessions: An innovative way of promoting physical activity in children and young people with obesity
    Liverpool, UK
    OC5.5
    Endocrine Oral Comms 2
    B-cell class switching in trans- and cis-gendered healthy young people is differentially influenced by sex hormones
    London, UK
    Endocrine Oral Comms 2
    Q&A
    11:55 - 12:25 
    Diabetes Oral Comms 1
    Chair: Melanie Kershaw (Birmingham, UK) and May Ng (Liverpool, UK)
    OC7.1
    Diabetes Oral Comms 1
    Utility of glycated haemoglobin in assessing abnormal glucose homeostasis in children and adolescents with obesity undergoing oral glucose tolerance test
    Bristol Royal Hospital for Children, Bristol, UK
    OC7.2
    Diabetes Oral Comms 1
    Multi-Centre Service Evaluation of Presentation of Newly Diagnosed Type 1 Diabetes in Children in the U.K. During the COVID-19 Pandemic
    University Hospital Wishaw, North Lanarkshire, UK
    OC7.3
    Diabetes Oral Comms 1
    Hybrid closed-loop in children and young people with type 1 diabetes improves glycaemic management and quality of life measures
    Southport and Ormskirk Hospital, Southport , UK
    OC7.4
    Diabetes Oral Comms 1
    Patient experiences of the changes made to the Cardiff and Vale University Health Board Paediatric Diabetes service due to COVID-19
    Cardiff University, Cardiff, UK
    OC7.5
    Diabetes Oral Comms 1
    Screening for Eating Disorders in Young People with Type 1 Diabetes
    UCL Medical School, London, UK
    UCL Medical School, London, UK
    Diabetes Oral Comms 1
    Q&A
    12:25 - 12:40 
    Break
    12:40 - 13:10 
    Industry Sponsored Expert Insights Session
    12:40 - 13:10 
    Industry Sponsored Expert Insights Session
    13:10 - 14:10 
    Lunch
    14:10 - 14:40 
    Awards Session - James M Tanner Award
    Chair: Tabitha Randell (Nottingham, UK) and Senthil Senniappan (Liverpool, UK)
    14:40 - 14:55 
    Break
    14:55 - 15:55 
    Endocrine Symposium 2
    Chair: Gary Butler (London, UK) and Bindu Avatapalle (Cardiff, UK)
    Endocrine Symposium 2
    GnRH analogues for gender dysphoria
    Amsterdam, The Netherlands
    Endocrine Symposium 2
    Using AMH and inhibin B assays in children and young people
    London, UK
    Endocrine Symposium 2
    Q&A
    14:55 - 15:55 
    Diabetes Symposium 3
    Chair: Ritika Kapoor (London, UK) and Chizo Agwu (Birmingham, UK)
    Diabetes Symposium 3
    Early detection of neonatal diabetes
    Royal Devon and Exeter NHS Foundation Trust, Exeter, UK
    Diabetes Symposium 3
    100 years of insulin - is it time for a UK Type 1 diabetes screening strategy?
    Oxford, UK
    Diabetes Symposium 3
    Q&A
    15:55 - 16:10 
    Break
    16:05 - 16:45 
    Personal Practice Session
    Chair: Mehul Dattani (London, UK) and Nikki Davis (Southampton, UK)
    Personal Practice Session
    Medical management of T2DM in adolescents
    Joslin Diabetes Centre, Boston, USA
    Personal Practice Session
    Management of thyroid nodules in children
    Philadelphia, USA
    Personal Practice Session
    Q&A
    16:10 - 16:40 
    Endocrine Oral Comms 3
    Chair: Dinesh Giri (Bristol, UK) and Nils Krone (Sheffield, UK)
    OC6.1
    Endocrine Oral Comms 3
    Novel dominant negative GH receptor variants provide important insights into GH receptor physiology
    Centre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University, London, UK
    OC6.2
    Endocrine Oral Comms 3
    Body composition in adults with genetically-confirmed Silver-Russell syndrome
    University of Southampton, Southampton, UK
    OC6.3
    Endocrine Oral Comms 3
    Topiramate as a treatment option in managing obesity complicated by idiopathic intracranial hypertension and chronic migraine in children and adolescents
    Department of Paediatric Endocrinology, Bristol Royal Hospital for Children, Bristol, UK
    OC6.4
    Endocrine Oral Comms 3
    Final height SDS of paediatric patients with ESRF that underwent renal transplantation
    Birmingham, UK
    OC6.5
    Endocrine Oral Comms 3
    Highlighting POLE1 mutations as a cause of adrenal insufficiency
    Norfolk and Norwich University Hospitals, Norwich, UK
    Jenny Lind Children’s Hospital, Norwich, UK
    Endocrine Oral Comms 3
    Q&A
    16:40 - 16:55 
    Break
    16:55 - 18:15 
    AGM

    09:00 - 09:30 
    Endocrine Nurses Business Meeting
    09:30 - 11:00 
    Diabetes Symposium 4
    Chair: Evelien Gevers (London, UK) and Fiona Campbell (Leeds, UK)
    Diabetes Symposium 4
    Optimising time in range using continuous glucose monitoring
    University of Leicester, Leicester, UK
    Diabetes Symposium 4
    Real world use of the closed loop insulin delivery system
    Cambridge, UK
    Cambridge, UK
    Diabetes Symposium 4
    Personalising insulin therapy using smart pumps, pens and automated insulin delivery systems
    Medical University of Graz, Graz, Austria
    Diabetes Symposium 4
    Q&A
    09:30 - 11:00 
    Endocrine Symposium 3
    Chair: Lee Martin (London, UK) and Isabelle Sharratt (London, UK)
    Endocrine Symposium 3
    Non-medical prescribing: how can you make a difference to your service as a non-medical prescriber?
    London South Bank University, London, UK
    Endocrine Symposium 3
    Advanced nurse practice: what is advanced nurse practice?
    London South Bank University, London, UK
    Endocrine Symposium 3
    Running a Paediatric Endocrine Nurse clinic: benefits and tips for success
    Alder Hey Children's Hospital, Liverpool, UK
    Endocrine Symposium 3
    Q&A
    11:00 - 11:15 
    Break
    11:15 - 12:45 
    Diabetes Oral Comms 2
    Chair: Chris Moudiotis (Exeter, UK) and Rathi Prasad (London, UK)
    OC8.1
    Diabetes Oral Comms 2
    Cystic fibrosis related diabetes (CFRD): could Cystic Fibrosis Transport Receptor (CFTR) modulators be the answer?
    Alder Hey Children's Healthcare Hospital, Liverpool, UK
    OC8.2
    Diabetes Oral Comms 2
    The cost of diabetes school training was halved whilst training 25% more staff during COVID-19 using multi-media interactive care plans
    Birmingham Women's and Children's Foundation Trust, Birmingham, UK
    Birmingham, UK
    OC8.3
    Diabetes Oral Comms 2
    Nottingham’s Robin Hood approach to socioeconomic and ethnic disparities in paediatric diabetes
    Nottingham University Hospitals NHS Trust, Nottingham, UK
    Nottingham University Hospitals NHS Trust, Nottingham, UK
    OC8.4
    Diabetes Oral Comms 2
    Developing a clinical decision aid for paediatric diabetic ketoacidosis: the DKA Calculator
    Bristol Royal Hospital for Children, Bristol, UK
    Diabetes Oral Comms 2
    Q&A
    OC8.5
    Diabetes Oral Comms 2
    Permanent neonatal diabetes due to KCNJ11 mutation: early successful transition to Glibenclamide and stable glucose profile with multiple daily dosing
    Bristol, UK
    OC8.6
    Diabetes Oral Comms 2
    Evaluation of the diabetes education app
    Nottingham University Hospitals NHS Trust, Nottingham, UK
    OC8.7
    Diabetes Oral Comms 2
    HENRY: High HbA1c service Evaluation 2016-2019: New “tipping point” in contactRequired for CYPwD
    Birmingham, UK
    OC8.8
    Diabetes Oral Comms 2
    Barriers to uploading diabetes technology at home
    Oxford University, Oxford, UK
    OC8.9
    Diabetes Oral Comms 2
    Virtual Sessions 'Cook and Count' for Young People with Type 1 Diabetes, Using PDSA Cycles, Meeting Young Peoples Wishes
    Royal Free NHS Trust, London, UK
    Royal Free NHS Trust, London, UK
    Diabetes Oral Comms 2
    Q&A
    11:15 - 12:15 
    Endocrine Oral Comms 4
    Chair: Susan Sparrow (Cambridge, UK) and Karis Reyes (Cambridge, UK)
    OC9.4
    Endocrine Oral Comms 4
    Changes in trends in Short Synacthen Test use over a decade - a single centre experience
    The University of Sheffield, Sheffield, UK
    OC9.1
    Endocrine Oral Comms 4
    Variability in the diagnosis of growth hormone deficiency using dynamic tests. Time for robust pre-test criteria?
    Medical Sciences Division, University of Oxford, Oxford, UK
    OC9.2
    Endocrine Oral Comms 4
    Sex Steroid Priming for Growth Hormone Stimulation Testing – A Systematic Review
    Edinburgh, UK
    OC9.3
    Endocrine Oral Comms 4
    Investigating paediatric weight management apps
    Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London, London, UK
    Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London, London, UK
    OC9.5
    Endocrine Oral Comms 4
    Variability of advice and education for steroid sick day dosing in Duchenne Muscular Dystrophy: Results of a UK patient survey
    Department of Endocrinology and Diabetes, Evelina London Children's Hospital, London, UK
    OC9.6
    Endocrine Oral Comms 4
    'Think Adrenal': An innovative trust-wide safety and education programme designed for the care of patients with adrenal insufficiency
    Great Ormond Street Hospital, London, UK
    Endocrine Oral Comms 4
    Q&A
    12:15 - 12:45 
    Presentations from Previous Award Winners
    Chair: Christina Wei (London, UK) and Jo Blair (Liverpool, UK)
    Presentations from Previous Award Winners
    BSPED Research & Innovation Award Winner 2017
    Newcastle University, Newcastle upon Tyne, UK
    Presentations from Previous Award Winners
    BSPED Research & Innovation Award Winner 2018
    Cardiff, UK
    Presentations from Previous Award Winners
    BSPED Research & Innovation Award Winner 2018
    Queen Mary University of London , London, UK
    Presentations from Previous Award Winners
    Q&A
    12:45 - 13:15 
    Lunch
    13:15 - 13:45 
    Industry Sponsored Expert Insights Session
    13:45 - 14:00 
    Break
    14:00 - 15:30 
    Diabetes Symposium 5
    Chair: Mars Skae (Manchester, UK) and Nicola Bridges (London, UK)
    Diabetes Symposium 5
    Effect of CFTR modulator therapy on cystic fibrosis-related diabetes
    University of Oklahoma Health Sciences Center, Oklahoma, USA
    Diabetes Symposium 5
    Evaluation and Management of Genetic forms of Obesity
    MRC Institute of Metabolic Science, Cambridge, UK
    Diabetes Symposium 5
    Psychoeducation and changing behaviour: Knowing how doesn’t always mean action
    University College London, London, UK
    Diabetes Symposium 5
    Q&A
    14:00 - 15:30 
    Endocrine Symposium 4
    Chair: Raja Padidela (Manchester, UK) and Renuka Ramakrishnan (Liverpool, UK)
    Endocrine Symposium 4
    Interpretation of abnormal thyroid function tests in children and adolescents
    Beacon Hospital and University College Dublin, Dublin, Ireland
    Endocrine Symposium 4
    Metabolic bone disease of prematurity: recognition, prevention and treatment
    Children's Hospital of Philadelphia, Philadelphia, USA
    Endocrine Symposium 4
    Newer treatment options for childhood obesity management
    University of Minnesota Medical School, Minnesota, USA
    Endocrine Symposium 4
    Q&A
    15:30 - 15:45 
    Break
    15:45 - 16:00 
    BSPED 2021 Awards Session
    Chair: Sabah Alvi (Leeds, UK) and Helen Storr (London, UK)
    16:00 - 16:15 
    Close of Meeting
    Chair: Senthil Senniappan (Liverpool, UK)
Malika Alimussina
Glasgow, UK
Thu 25 12:05
OC5.3
Endocrine Oral Comms 2
An Investigation Of Androgen-responsive Non-coding RNAs In Boys With Atypical Genitalia Without Genetic Variants in the Androgen Receptor (AR)
Glasgow, UK
Afiya Andrews
Centre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University, London, UK
Thu 25 16:10
OC6.1
Endocrine Oral Comms 3
Novel dominant negative GH receptor variants provide important insights into GH receptor physiology
Centre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University, London, UK
Louise Apperley
Alder Hey Children's Hospital, Liverpool, UK
Thu 25 10:20
OC4.9
Endocrine Oral Comms 1
The use of Liraglutide in the treatment of childhood obesity
Alder Hey Children's Hospital, Liverpool, UK
Sithara Ayamad
Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London, London, UK
Fri 26 11:36
OC9.3
Endocrine Oral Comms 4
Investigating paediatric weight management apps
Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London, London, UK
Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London, London, UK
Irina A Bacila
Sheffield, UK
Thu 25 10:04
OC4.7
Endocrine Oral Comms 1
The use of urinary steroid profiles in monitoring therapy in children with 21-hydroxylase deficiency – results from the CAH-UK cohort study
Sheffield, UK
Professor Tadej Battelino
University of Ljublijana, Ljubljana, Slovenia
Wed 24 15:40
CME Session 4
Updating Diabetes care with advances in diabetes technology and digital health
University of Ljublijana, Ljubljana, Slovenia
Andrew Bauer
Philadelphia, USA
Thu 25 16:20
Personal Practice Session
Management of thyroid nodules in children
Philadelphia, USA
Karen Bell
RBHSC, Belfast, UK
Wed 24 10:15
OC1.1
CME Case Presentations 1
Severe hypercalcaemia in Williams-Beuren syndrome
RBHSC, Belfast, UK
Rachel Besser
Oxford, UK
Thu 25 15:15
Diabetes Symposium 3
100 years of insulin - is it time for a UK Type 1 diabetes screening strategy?
Oxford, UK
Detlef  Bockenhauer
Leuven, Belgium
Wed 24 09:30
CME Session 1
Kidney speaks - Interpreting kidney function tests in disorders of salt and water balance
Leuven, Belgium
Megan Bone
Cardiff University, Cardiff, UK
Thu 25 12:10
OC7.4
Diabetes Oral Comms 1
Patient experiences of the changes made to the Cardiff and Vale University Health Board Paediatric Diabetes service due to COVID-19
Cardiff University, Cardiff, UK
Dr Elizabeth Boxel
Oxford University, Oxford, UK
Fri 26 12:19
OC8.8
Diabetes Oral Comms 2
Barriers to uploading diabetes technology at home
Oxford University, Oxford, UK
Nirit Braha
UCL Medical School, London, UK
Thu 25 12:15
OC7.5
Diabetes Oral Comms 1
Screening for Eating Disorders in Young People with Type 1 Diabetes
UCL Medical School, London, UK
UCL Medical School, London, UK
Professor Gary Butler
London, UK
Thu 25 10:12
OC4.8
Endocrine Oral Comms 1
Destination outcome of 1151 gender variant young people presenting to paediatric endocrinology clinics in England and Wales since 2008
London, UK
Professor Andrew Calabria
Children's Hospital of Philadelphia, Philadelphia, USA
Fri 26 14:20
Endocrine Symposium 4
Metabolic bone disease of prematurity: recognition, prevention and treatment
Children's Hospital of Philadelphia, Philadelphia, USA
Toby Candler
Cardiff, UK
Fri 26 12:23
Presentations from Previous Award Winners
BSPED Research & Innovation Award Winner 2018
Cardiff, UK
Professor Li Chan
Queen Mary University of London , London, UK
Fri 26 12:31
Presentations from Previous Award Winners
BSPED Research & Innovation Award Winner 2018
Queen Mary University of London , London, UK
Pratik Choudhary
University of Leicester, Leicester, UK
Fri 26 09:30
Diabetes Symposium 4
Optimising time in range using continuous glucose monitoring
University of Leicester, Leicester, UK
Deborah Christie
University College London, London, UK
Fri 26 14:40
Diabetes Symposium 5
Psychoeducation and changing behaviour: Knowing how doesn’t always mean action
University College London, London, UK
Ellie Clarke
Liverpool, UK
Thu 25 12:10
OC5.4
Endocrine Oral Comms 2
Virtual exercise sessions: An innovative way of promoting physical activity in children and young people with obesity
Liverpool, UK
Louise Collins
Birmingham Women's and Children's Foundation Trust, Birmingham, UK
Fri 26 11:23
OC8.2
Diabetes Oral Comms 2
The cost of diabetes school training was halved whilst training 25% more staff during COVID-19 using multi-media interactive care plans
Birmingham Women's and Children's Foundation Trust, Birmingham, UK
Birmingham, UK
Kate Costello
Royal Free NHS Trust, London, UK
Fri 26 12:27
OC8.9
Diabetes Oral Comms 2
Virtual Sessions 'Cook and Count' for Young People with Type 1 Diabetes, Using PDSA Cycles, Meeting Young Peoples Wishes
Royal Free NHS Trust, London, UK
Royal Free NHS Trust, London, UK
Dr Emily Cottrell
London, UK
Thu 25 09:26
OC4.3
Endocrine Oral Comms 1
Growth hormone receptor 6Ω pseudoexon activation: a novel cause of severe growth hormone insensitivity
London, UK
Kate Davies
London South Bank University, London, UK
Fri 26 09:30
Endocrine Symposium 3
Non-medical prescribing: how can you make a difference to your service as a non-medical prescriber?
London South Bank University, London, UK
Madhuvanthi Dhamodaran
Norfolk and Norwich University Hospitals, Norwich, UK
Thu 25 16:30
OC6.5
Endocrine Oral Comms 3
Highlighting POLE1 mutations as a cause of adrenal insufficiency
Norfolk and Norwich University Hospitals, Norwich, UK
Jenny Lind Children’s Hospital, Norwich, UK
Dr Renuka Dias
Birmingham, UK
Thu 25 16:25
OC6.4
Endocrine Oral Comms 3
Final height SDS of paediatric patients with ESRF that underwent renal transplantation
Birmingham, UK
Victoria Dublon
Royal Free NHS Trust, London, UK
Fri 26 12:27
OC8.9
Diabetes Oral Comms 2
Virtual Sessions 'Cook and Count' for Young People with Type 1 Diabetes, Using PDSA Cycles, Meeting Young Peoples Wishes
Royal Free NHS Trust, London, UK
Royal Free NHS Trust, London, UK
Professor Sadaf Farooqi
MRC Institute of Metabolic Science, Cambridge, UK
Fri 26 14:20
Diabetes Symposium 5
Evaluation and Management of Genetic forms of Obesity
MRC Institute of Metabolic Science, Cambridge, UK
Elspeth Ferguson
Sheffield, UK
Wed 24 12:15
OC2.1
CME Case Presentations 2
Pitfalls and challenges in the diagnosis and management of Cushing’s disease in children: An interesting case
Sheffield, UK
Dr Claudia Fox
University of Minnesota Medical School, Minnesota, USA
Fri 26 14:40
Endocrine Symposium 4
Newer treatment options for childhood obesity management
University of Minnesota Medical School, Minnesota, USA
Natasha Franklin
Department of Paediatric Endocrinology, Bristol Children's Hospital, Bristol, UK
Wed 24 15:15
OC3.2
CME Case Presentations 3
Variable responses to sulfonylurea treatment in siblings from the same family with monogenic diabetes due to HNF1A mutation
Department of Paediatric Endocrinology, Bristol Children's Hospital, Bristol, UK
Nicole Goff
London, UK
Thu 25 09:56
OC4.6
Endocrine Oral Comms 1
The management of adrenal cell carcinoma in the United Kingdom at a single centre: a 25 year experience
London, UK
Harriet Gunn
London, UK
Thu 25 09:32
OC4.4
Endocrine Oral Comms 1
Does Inflammation Underpin Polycystic Ovary Syndrome (PCOS)? A Proteomic Approach to Novel Non-Invasive Biomarker and Pathway Discovery in Adolescent PCOS
London, UK
Dr Sabine Hannema
Amsterdam, The Netherlands
Thu 25 14:55
Endocrine Symposium 2
GnRH analogues for gender dysphoria
Amsterdam, The Netherlands
Frances Hanson
Leeds Children’s Hospital, Leeds, UK
Thu 25 09:10
Diabetes Symposium 1
Low carbohydrate diets in type 1 diabetes
Leeds Children’s Hospital, Leeds, UK
Katherine Hawton
Bristol, UK
Wed 24 15:10
OC3.1
CME Case Presentations 3
Rapid-Onset Obesity, Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation Syndrome (ROHHAD-NET): Case series & learning points
Bristol, UK
Fri 26 11:55
OC8.5
Diabetes Oral Comms 2
Permanent neonatal diabetes due to KCNJ11 mutation: early successful transition to Glibenclamide and stable glucose profile with multiple daily dosing
Bristol, UK
Sarah Hill
Nottingham University Hospitals NHS Trust, Nottingham, UK
Fri 26 11:31
OC8.3
Diabetes Oral Comms 2
Nottingham’s Robin Hood approach to socioeconomic and ethnic disparities in paediatric diabetes
Nottingham University Hospitals NHS Trust, Nottingham, UK
Nottingham University Hospitals NHS Trust, Nottingham, UK
Roman Hovorka
Cambridge, UK
Fri 26 09:50
Diabetes Symposium 4
Real world use of the closed loop insulin delivery system
Cambridge, UK
Cambridge, UK
Dr Sasha Howard
London, UK
Thu 25 09:10
OC4.1
Endocrine Oral Comms 1
Dominant Mutations in CCDC141 are found by Whole Exome Sequencing to be a Common Cause of Self-Limited Delayed Puberty
London, UK
Thu 25 15:15
Endocrine Symposium 2
Using AMH and inhibin B assays in children and young people
London, UK
Tony Hulse
Maidstone, UK
Thu 25 12:00
OC5.2
Endocrine Oral Comms 2
Evaluation of the discrepancy between free thyroxine (FT4) reference ranges and the impact on clinical investigation of central hypothyroidism
Maidstone, UK
Maidstone, UK
Professor Lourdes Ibanez
Sant Joan de Déu Hospital Barcelona, Barcelona, Spain
Wed 24 11:00
CME Session 2
Update in the recognition and management of adolescent PCOS
Sant Joan de Déu Hospital Barcelona, Barcelona, Spain
Dr Elvira Isganaitis
Joslin Diabetes Centre, Boston, USA
Thu 25 16:05
Personal Practice Session
Medical management of T2DM in adolescents
Joslin Diabetes Centre, Boston, USA
Rebecca Jacob
UCL Medical School, London, UK
Thu 25 12:15
OC7.5
Diabetes Oral Comms 1
Screening for Eating Disorders in Young People with Type 1 Diabetes
UCL Medical School, London, UK
UCL Medical School, London, UK
Dr Hiba Jebeile
University of Sydney, Sydney, Australia
Thu 25 09:30
Diabetes Symposium 1
Eating disorder risk in weight management
University of Sydney, Sydney, Australia
Professor  Partha Kar
Portsmouth Hospital, Portsmouth, UK
Thu 25 11:15
Diabetes Symposium 2
Type 1 diabetes: moving into adulthood
Portsmouth Hospital, Portsmouth, UK
Nancy Katkat
Southport and Ormskirk Hospital, Southport , UK
Thu 25 12:05
OC7.3
Diabetes Oral Comms 1
Hybrid closed-loop in children and young people with type 1 diabetes improves glycaemic management and quality of life measures
Southport and Ormskirk Hospital, Southport , UK
Peter Laing
Alder Hey Children's Hospital, Liverpool, UK
Fri 26 10:10
Endocrine Symposium 3
Running a Paediatric Endocrine Nurse clinic: benefits and tips for success
Alder Hey Children's Hospital, Liverpool, UK
Daniel Leach
Bristol Royal Hospital for Children, Bristol, UK
Fri 26 11:39
OC8.4
Diabetes Oral Comms 2
Developing a clinical decision aid for paediatric diabetic ketoacidosis: the DKA Calculator
Bristol Royal Hospital for Children, Bristol, UK
Oluwakemi Lokulo-Sodipe
University of Southampton, Southampton, UK
Thu 25 16:15
OC6.2
Endocrine Oral Comms 3
Body composition in adults with genetically-confirmed Silver-Russell syndrome
University of Southampton, Southampton, UK
Professor Robert  Lustig
San Francisco, USA
Wed 24 14:25
CME Session 3
Hypothalamic obesity post cancer treatment - optimising outcomes
San Francisco, USA
Dr Julia Mader
Medical University of Graz, Graz, Austria
Fri 26 10:10
Diabetes Symposium 4
Personalising insulin therapy using smart pumps, pens and automated insulin delivery systems
Medical University of Graz, Graz, Austria
Aayan Matan
Bristol Royal Hospital for Children, Bristol, UK
Thu 25 11:55
OC7.1
Diabetes Oral Comms 1
Utility of glycated haemoglobin in assessing abnormal glucose homeostasis in children and adolescents with obesity undergoing oral glucose tolerance test
Bristol Royal Hospital for Children, Bristol, UK
Rhianwen  Mathews
Department of Paediatric Endocrinology, Bristol Royal Hospital for Children, Bristol, UK
Thu 25 16:20
OC6.3
Endocrine Oral Comms 3
Topiramate as a treatment option in managing obesity complicated by idiopathic intracranial hypertension and chronic migraine in children and adolescents
Department of Paediatric Endocrinology, Bristol Royal Hospital for Children, Bristol, UK
Professor Rory McCrimmon
University of Dundee, Dundee, UK
Wed 24 16:05
CME Session 4
Hypoglycemia unawareness in type 1 diabetes – lessons learnt
University of Dundee, Dundee, UK
Dr David McGregor
Royal Devon and Exeter NHS Foundation Trust, Exeter, UK
Thu 25 14:55
Diabetes Symposium 3
Early detection of neonatal diabetes
Royal Devon and Exeter NHS Foundation Trust, Exeter, UK
Ross McLean
University Hospital Wishaw, North Lanarkshire, UK
Thu 25 12:00
OC7.2
Diabetes Oral Comms 1
Multi-Centre Service Evaluation of Presentation of Newly Diagnosed Type 1 Diabetes in Children in the U.K. During the COVID-19 Pandemic
University Hospital Wishaw, North Lanarkshire, UK
Dr Joanne  McManus
Medical Associates, Belfast, Ireland
Thu 25 11:15
Endocrine Symposium 1
Turner syndrome adolescence and beyond
Medical Associates, Belfast, Ireland
Professor Rod Mitchell
Edinburgh, UK
Thu 25 10:55
Endocrine Symposium 1
Fertility preservation in boys
Edinburgh, UK
Fri 26 11:29
OC9.2
Endocrine Oral Comms 4
Sex Steroid Priming for Growth Hormone Stimulation Testing – A Systematic Review
Edinburgh, UK
Mustafa Mohebi
Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London, London, UK
Fri 26 11:36
OC9.3
Endocrine Oral Comms 4
Investigating paediatric weight management apps
Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London, London, UK
Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London, London, UK
Carla Moran
Beacon Hospital and University College Dublin, Dublin, Ireland
Fri 26 14:00
Endocrine Symposium 4
Interpretation of abnormal thyroid function tests in children and adolescents
Beacon Hospital and University College Dublin, Dublin, Ireland
Professor Anna Nordenström
Karolinska University Hospital, Stockholm, Sweden
Wed 24 11:30
CME Session 2
Approach to a viralising girl in puberty
Karolinska University Hospital, Stockholm, Sweden
Julie Park
Alder Hey Children's Healthcare Hospital, Liverpool, UK
Fri 26 11:15
OC8.1
Diabetes Oral Comms 2
Cystic fibrosis related diabetes (CFRD): could Cystic Fibrosis Transport Receptor (CFTR) modulators be the answer?
Alder Hey Children's Healthcare Hospital, Liverpool, UK
Hannah Peckham
London, UK
Thu 25 12:15
OC5.5
Endocrine Oral Comms 2
B-cell class switching in trans- and cis-gendered healthy young people is differentially influenced by sex hormones
London, UK
John Pemberton
Birmingham, UK
Fri 26 11:23
OC8.2
Diabetes Oral Comms 2
The cost of diabetes school training was halved whilst training 25% more staff during COVID-19 using multi-media interactive care plans
Birmingham Women's and Children's Foundation Trust, Birmingham, UK
Birmingham, UK
Fri 26 12:11
OC8.7
Diabetes Oral Comms 2
HENRY: High HbA1c service Evaluation 2016-2019: New “tipping point” in contactRequired for CYPwD
Birmingham, UK
Dr Philippa Prentice
North Middlesex Hospital, London, UK
Thu 25 09:18
OC4.2
Endocrine Oral Comms 1
Pseudohypoparathyroidism type 1A and 1B: presentation, phenotypes and phenotype-genotype associations
North Middlesex Hospital, London, UK
Callum  Ross
The University of Sheffield, Sheffield, UK
Fri 26 11:15
OC9.4
Endocrine Oral Comms 4
Changes in trends in Short Synacthen Test use over a decade - a single centre experience
The University of Sheffield, Sheffield, UK
Professor R. Louise Rushworth
Sydney Clinical School, University of Notre Dame Australia, Sydney, Australia
Wed 24 09:00
CME Session 1
Epidemiology of adrenal crisis in children
Sydney Clinical School, University of Notre Dame Australia, Sydney, Australia
Professor Hal Scofield
University of Oklahoma Health Sciences Center, Oklahoma, USA
Fri 26 14:00
Diabetes Symposium 5
Effect of CFTR modulator therapy on cystic fibrosis-related diabetes
University of Oklahoma Health Sciences Center, Oklahoma, USA
Meera  Shaunak
London, UK
Wed 24 10:25
OC1.2
CME Case Presentations 1
Two cases of functioning adrenocortical tumours secondary to TP53 variants
London, UK
Jananie  Suntharesan
Alder Hey Children's Hospital, Liverpool, UK
Wed 24 12:25
OC2.2
CME Case Presentations 2
Two cases of McCune-Albright Syndrome with multisystem involvement
Alder Hey Children's Hospital, Liverpool, UK
Rabbi Swaby
Nottingham University Hospitals NHS Trust, Nottingham, UK
Fri 26 11:31
OC8.3
Diabetes Oral Comms 2
Nottingham’s Robin Hood approach to socioeconomic and ethnic disparities in paediatric diabetes
Nottingham University Hospitals NHS Trust, Nottingham, UK
Nottingham University Hospitals NHS Trust, Nottingham, UK
Fri 26 12:03
OC8.6
Diabetes Oral Comms 2
Evaluation of the diabetes education app
Nottingham University Hospitals NHS Trust, Nottingham, UK
Dr Rum Thomas
Sheffield Children's NHS Foundation Trust, Sheffield, UK
Thu 25 10:55
Diabetes Symposium 2
Controversies in the management of DKA
Sheffield Children's NHS Foundation Trust, Sheffield, UK
Dr Paul Thornton
Texas, USA
Wed 24 13:55
CME Session 3
Controversies in management of neonatal hypoglycaemia
Texas, USA
Sally Tollerfield
Great Ormond Street Hospital, London, UK
Fri 26 11:50
OC9.6
Endocrine Oral Comms 4
'Think Adrenal': An innovative trust-wide safety and education programme designed for the care of patients with adrenal insufficiency
Great Ormond Street Hospital, London, UK
Dr David  Unwin
RCGP Clinical Expert in Diabetes, Southport, UK
Thu 25 09:50
Diabetes Symposium 1
Low carbohydrate diets in type 2 diabetes
RCGP Clinical Expert in Diabetes, Southport, UK
Susan  Vickery
Maidstone, UK
Thu 25 12:00
OC5.2
Endocrine Oral Comms 2
Evaluation of the discrepancy between free thyroxine (FT4) reference ranges and the impact on clinical investigation of central hypothyroidism
Maidstone, UK
Maidstone, UK
Dr Julia Ware
Cambridge, UK
Fri 26 09:50
Diabetes Symposium 4
Real world use of the closed loop insulin delivery system
Cambridge, UK
Cambridge, UK
Gemma Watts
Queen Alexandra Hospital, Portsmouth, UK
Thu 25 09:48
OC4.5
Endocrine Oral Comms 1
The biochemical evaluation of Metabolic Bone Disease of Prematurity (MBDP) in a high-risk population
Queen Alexandra Hospital, Portsmouth, UK
Dr Emma Webb
Jenny Lind Children’s Hospital, Norwich, UK
Thu 25 16:30
OC6.5
Endocrine Oral Comms 3
Highlighting POLE1 mutations as a cause of adrenal insufficiency
Norfolk and Norwich University Hospitals, Norwich, UK
Jenny Lind Children’s Hospital, Norwich, UK
Gemma White
London, UK
Thu 25 11:55
OC5.1
Endocrine Oral Comms 2
Evaluating UK Referral Criteria for Children with Short Stature in a Tertiary Paediatric Endocrinology Centre
London, UK
Stephen-Andrew Whyte
London South Bank University, London, UK
Fri 26 09:50
Endocrine Symposium 3
Advanced nurse practice: what is advanced nurse practice?
London South Bank University, London, UK
SC Wong
Department of Endocrinology and Diabetes, Evelina London Children's Hospital, London, UK
Fri 26 11:43
OC9.5
Endocrine Oral Comms 4
Variability of advice and education for steroid sick day dosing in Duchenne Muscular Dystrophy: Results of a UK patient survey
Department of Endocrinology and Diabetes, Evelina London Children's Hospital, London, UK
Claire Wood
Newcastle University, Newcastle upon Tyne, UK
Fri 26 12:15
Presentations from Previous Award Winners
BSPED Research & Innovation Award Winner 2017
Newcastle University, Newcastle upon Tyne, UK
Eva  Zilber
Medical Sciences Division, University of Oxford, Oxford, UK
Fri 26 11:22
OC9.1
Endocrine Oral Comms 4
Variability in the diagnosis of growth hormone deficiency using dynamic tests. Time for robust pre-test criteria?
Medical Sciences Division, University of Oxford, Oxford, UK
Workshop 1
Wed 24 12:45
CSAC Trainee Representative
Oral 9
Wed 24 10:15
CME Case Presentations 1
Chair: Anitha Kumaran (Southampton, UK) and James Law (Nottingham, UK)
Wed 24 10:15
OC1.1
CME Case Presentations 1
Severe hypercalcaemia in Williams-Beuren syndrome
RBHSC, Belfast, UK
Wed 24 10:25
OC1.2
CME Case Presentations 1
Two cases of functioning adrenocortical tumours secondary to TP53 variants
London, UK
Wed 24 10:35
CME Case Presentations 1
Q&A
Wed 24 12:15
CME Case Presentations 2
Chair: Anitha Kumaran (Southampton, UK) and Charlotte Elder (Sheffield, UK)
Wed 24 12:15
OC2.1
CME Case Presentations 2
Pitfalls and challenges in the diagnosis and management of Cushing’s disease in children: An interesting case
Sheffield, UK
Wed 24 12:25
OC2.2
CME Case Presentations 2
Two cases of McCune-Albright Syndrome with multisystem involvement
Alder Hey Children's Hospital, Liverpool, UK
Wed 24 12:35
CME Case Presentations 2
Q&A
Wed 24 15:10
CME Case Presentations 3
Chair: Anitha Kumaran (Southampton, UK) and Senthil Senniappan (Liverpool, UK)
Wed 24 15:10
OC3.1
CME Case Presentations 3
Rapid-Onset Obesity, Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation Syndrome (ROHHAD-NET): Case series & learning points
Bristol, UK
Wed 24 15:15
OC3.2
CME Case Presentations 3
Variable responses to sulfonylurea treatment in siblings from the same family with monogenic diabetes due to HNF1A mutation
Department of Paediatric Endocrinology, Bristol Children's Hospital, Bristol, UK
Wed 24 15:20
CME Case Presentations 3
Q&A
Thu 25 09:10
Endocrine Oral Comms 1
Chair: Hoong-Wei Gan (London, UK) and Justin Davies (Southampton, UK)
Thu 25 09:10
OC4.1
Endocrine Oral Comms 1
Dominant Mutations in CCDC141 are found by Whole Exome Sequencing to be a Common Cause of Self-Limited Delayed Puberty
London, UK
Thu 25 09:18
OC4.2
Endocrine Oral Comms 1
Pseudohypoparathyroidism type 1A and 1B: presentation, phenotypes and phenotype-genotype associations
North Middlesex Hospital, London, UK
Thu 25 09:26
OC4.3
Endocrine Oral Comms 1
Growth hormone receptor 6Ω pseudoexon activation: a novel cause of severe growth hormone insensitivity
London, UK
Thu 25 09:32
OC4.4
Endocrine Oral Comms 1
Does Inflammation Underpin Polycystic Ovary Syndrome (PCOS)? A Proteomic Approach to Novel Non-Invasive Biomarker and Pathway Discovery in Adolescent PCOS
London, UK
Thu 25 09:40
Endocrine Oral Comms 1
Q&A
Thu 25 09:48
OC4.5
Endocrine Oral Comms 1
The biochemical evaluation of Metabolic Bone Disease of Prematurity (MBDP) in a high-risk population
Queen Alexandra Hospital, Portsmouth, UK
Thu 25 09:56
OC4.6
Endocrine Oral Comms 1
The management of adrenal cell carcinoma in the United Kingdom at a single centre: a 25 year experience
London, UK
Thu 25 10:04
OC4.7
Endocrine Oral Comms 1
The use of urinary steroid profiles in monitoring therapy in children with 21-hydroxylase deficiency – results from the CAH-UK cohort study
Sheffield, UK
Thu 25 10:12
OC4.8
Endocrine Oral Comms 1
Destination outcome of 1151 gender variant young people presenting to paediatric endocrinology clinics in England and Wales since 2008
London, UK
Thu 25 10:20
OC4.9
Endocrine Oral Comms 1
The use of Liraglutide in the treatment of childhood obesity
Alder Hey Children's Hospital, Liverpool, UK
Thu 25 10:28
Endocrine Oral Comms 1
Q&A
Thu 25 11:55
Endocrine Oral Comms 2
Chair: Renuka Dias (Birmingham, UK) and Pooja Sachdev (Nottingham, UK)
Thu 25 11:55
OC5.1
Endocrine Oral Comms 2
Evaluating UK Referral Criteria for Children with Short Stature in a Tertiary Paediatric Endocrinology Centre
London, UK
Thu 25 12:00
OC5.2
Endocrine Oral Comms 2
Evaluation of the discrepancy between free thyroxine (FT4) reference ranges and the impact on clinical investigation of central hypothyroidism
Maidstone, UK
Maidstone, UK
Thu 25 12:05
OC5.3
Endocrine Oral Comms 2
An Investigation Of Androgen-responsive Non-coding RNAs In Boys With Atypical Genitalia Without Genetic Variants in the Androgen Receptor (AR)
Glasgow, UK
Thu 25 12:10
OC5.4
Endocrine Oral Comms 2
Virtual exercise sessions: An innovative way of promoting physical activity in children and young people with obesity
Liverpool, UK
Thu 25 12:15
OC5.5
Endocrine Oral Comms 2
B-cell class switching in trans- and cis-gendered healthy young people is differentially influenced by sex hormones
London, UK
Thu 25 12:20
Endocrine Oral Comms 2
Q&A
Thu 25 11:55
Diabetes Oral Comms 1
Chair: Melanie Kershaw (Birmingham, UK) and May Ng (Liverpool, UK)
Thu 25 11:55
OC7.1
Diabetes Oral Comms 1
Utility of glycated haemoglobin in assessing abnormal glucose homeostasis in children and adolescents with obesity undergoing oral glucose tolerance test
Bristol Royal Hospital for Children, Bristol, UK
Thu 25 12:00
OC7.2
Diabetes Oral Comms 1
Multi-Centre Service Evaluation of Presentation of Newly Diagnosed Type 1 Diabetes in Children in the U.K. During the COVID-19 Pandemic
University Hospital Wishaw, North Lanarkshire, UK
Thu 25 12:05
OC7.3
Diabetes Oral Comms 1
Hybrid closed-loop in children and young people with type 1 diabetes improves glycaemic management and quality of life measures
Southport and Ormskirk Hospital, Southport , UK
Thu 25 12:10
OC7.4
Diabetes Oral Comms 1
Patient experiences of the changes made to the Cardiff and Vale University Health Board Paediatric Diabetes service due to COVID-19
Cardiff University, Cardiff, UK
Thu 25 12:15
OC7.5
Diabetes Oral Comms 1
Screening for Eating Disorders in Young People with Type 1 Diabetes
UCL Medical School, London, UK
UCL Medical School, London, UK
Thu 25 12:20
Diabetes Oral Comms 1
Q&A
Thu 25 16:10
Endocrine Oral Comms 3
Chair: Dinesh Giri (Bristol, UK) and Nils Krone (Sheffield, UK)
Thu 25 16:10
OC6.1
Endocrine Oral Comms 3
Novel dominant negative GH receptor variants provide important insights into GH receptor physiology
Centre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University, London, UK
Thu 25 16:15
OC6.2
Endocrine Oral Comms 3
Body composition in adults with genetically-confirmed Silver-Russell syndrome
University of Southampton, Southampton, UK
Thu 25 16:20
OC6.3
Endocrine Oral Comms 3
Topiramate as a treatment option in managing obesity complicated by idiopathic intracranial hypertension and chronic migraine in children and adolescents
Department of Paediatric Endocrinology, Bristol Royal Hospital for Children, Bristol, UK
Thu 25 16:25
OC6.4
Endocrine Oral Comms 3
Final height SDS of paediatric patients with ESRF that underwent renal transplantation
Birmingham, UK
Thu 25 16:30
OC6.5
Endocrine Oral Comms 3
Highlighting POLE1 mutations as a cause of adrenal insufficiency
Norfolk and Norwich University Hospitals, Norwich, UK
Jenny Lind Children’s Hospital, Norwich, UK
Thu 25 16:35
Endocrine Oral Comms 3
Q&A
Fri 26 11:15
Diabetes Oral Comms 2
Chair: Chris Moudiotis (Exeter, UK) and Rathi Prasad (London, UK)
Fri 26 11:15
OC8.1
Diabetes Oral Comms 2
Cystic fibrosis related diabetes (CFRD): could Cystic Fibrosis Transport Receptor (CFTR) modulators be the answer?
Alder Hey Children's Healthcare Hospital, Liverpool, UK
Fri 26 11:23
OC8.2
Diabetes Oral Comms 2
The cost of diabetes school training was halved whilst training 25% more staff during COVID-19 using multi-media interactive care plans
Birmingham Women's and Children's Foundation Trust, Birmingham, UK
Birmingham, UK
Fri 26 11:31
OC8.3
Diabetes Oral Comms 2
Nottingham’s Robin Hood approach to socioeconomic and ethnic disparities in paediatric diabetes
Nottingham University Hospitals NHS Trust, Nottingham, UK
Nottingham University Hospitals NHS Trust, Nottingham, UK
Fri 26 11:39
OC8.4
Diabetes Oral Comms 2
Developing a clinical decision aid for paediatric diabetic ketoacidosis: the DKA Calculator
Bristol Royal Hospital for Children, Bristol, UK
Fri 26 11:47
Diabetes Oral Comms 2
Q&A
Fri 26 11:55
OC8.5
Diabetes Oral Comms 2
Permanent neonatal diabetes due to KCNJ11 mutation: early successful transition to Glibenclamide and stable glucose profile with multiple daily dosing
Bristol, UK
Fri 26 12:03
OC8.6
Diabetes Oral Comms 2
Evaluation of the diabetes education app
Nottingham University Hospitals NHS Trust, Nottingham, UK
Fri 26 12:11
OC8.7
Diabetes Oral Comms 2
HENRY: High HbA1c service Evaluation 2016-2019: New “tipping point” in contactRequired for CYPwD
Birmingham, UK
Fri 26 12:19
OC8.8
Diabetes Oral Comms 2
Barriers to uploading diabetes technology at home
Oxford University, Oxford, UK
Fri 26 12:27
OC8.9
Diabetes Oral Comms 2
Virtual Sessions 'Cook and Count' for Young People with Type 1 Diabetes, Using PDSA Cycles, Meeting Young Peoples Wishes
Royal Free NHS Trust, London, UK
Royal Free NHS Trust, London, UK
Fri 26 12:35
Diabetes Oral Comms 2
Q&A
Fri 26 11:15
Endocrine Oral Comms 4
Chair: Susan Sparrow (Cambridge, UK) and Karis Reyes (Cambridge, UK)
Fri 26 11:15
OC9.4
Endocrine Oral Comms 4
Changes in trends in Short Synacthen Test use over a decade - a single centre experience
The University of Sheffield, Sheffield, UK
Fri 26 11:22
OC9.1
Endocrine Oral Comms 4
Variability in the diagnosis of growth hormone deficiency using dynamic tests. Time for robust pre-test criteria?
Medical Sciences Division, University of Oxford, Oxford, UK
Fri 26 11:29
OC9.2
Endocrine Oral Comms 4
Sex Steroid Priming for Growth Hormone Stimulation Testing – A Systematic Review
Edinburgh, UK
Fri 26 11:36
OC9.3
Endocrine Oral Comms 4
Investigating paediatric weight management apps
Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London, London, UK
Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London, London, UK
Fri 26 11:43
OC9.5
Endocrine Oral Comms 4
Variability of advice and education for steroid sick day dosing in Duchenne Muscular Dystrophy: Results of a UK patient survey
Department of Endocrinology and Diabetes, Evelina London Children's Hospital, London, UK
Fri 26 11:50
OC9.6
Endocrine Oral Comms 4
'Think Adrenal': An innovative trust-wide safety and education programme designed for the care of patients with adrenal insufficiency
Great Ormond Street Hospital, London, UK
Fri 26 11:57
Endocrine Oral Comms 4
Q&A
Expert 2
Thu 25 12:40
Industry Sponsored Expert Insights Session
Thu 25 12:40
Industry Sponsored Expert Insights Session
Plenary 10
Wed 24 09:00
CME Session 1
Chair: Anitha Kumaran (Southampton, UK) and James Law (Nottingham, UK)
Wed 24 09:00
CME Session 1
Epidemiology of adrenal crisis in children
Sydney Clinical School, University of Notre Dame Australia, Sydney, Australia
Wed 24 09:30
CME Session 1
Kidney speaks - Interpreting kidney function tests in disorders of salt and water balance
Leuven, Belgium
Wed 24 10:00
CME Session 1
Q&A
Wed 24 11:00
CME Session 2
Chair: Anitha Kumaran (Southampton, UK) and Charlotte Elder (Sheffield, UK)
Wed 24 11:00
CME Session 2
Update in the recognition and management of adolescent PCOS
Sant Joan de Déu Hospital Barcelona, Barcelona, Spain
Wed 24 11:30
CME Session 2
Approach to a viralising girl in puberty
Karolinska University Hospital, Stockholm, Sweden
Wed 24 12:00
CME Session 2
Q&A
Wed 24 13:55
CME Session 3
Chair: Anitha Kumaran (Southampton, UK) and Senthil Senniappan (Liverpool, UK)
Wed 24 13:55
CME Session 3
Controversies in management of neonatal hypoglycaemia
Texas, USA
Wed 24 14:25
CME Session 3
Hypothalamic obesity post cancer treatment - optimising outcomes
San Francisco, USA
Wed 24 14:55
CME Session 3
Q&A
Wed 24 15:40
CME Session 4
Chair: Anitha Kumaran (Southampton, UK) and Dr Sophia Sakka (London, UK)
Wed 24 15:40
CME Session 4
Updating Diabetes care with advances in diabetes technology and digital health
University of Ljublijana, Ljubljana, Slovenia
Wed 24 16:05
CME Session 4
Hypoglycemia unawareness in type 1 diabetes – lessons learnt
University of Dundee, Dundee, UK
Wed 24 16:30
CME Session 4
Q&A
Thu 25 09:10
Diabetes Symposium 1
Chair: Tabitha Randell (Nottingham, UK) and Amanda Peacock (Leeds, UK)
Thu 25 09:10
Diabetes Symposium 1
Low carbohydrate diets in type 1 diabetes
Leeds Children’s Hospital, Leeds, UK
Thu 25 09:30
Diabetes Symposium 1
Eating disorder risk in weight management
University of Sydney, Sydney, Australia
Thu 25 09:50
Diabetes Symposium 1
Low carbohydrate diets in type 2 diabetes
RCGP Clinical Expert in Diabetes, Southport, UK
Thu 25 10:10
Diabetes Symposium 1
Q&A
Thu 25 10:55
Diabetes Symposium 2
Chair: Noina Abid (Belfast, Northern Ireland) and Neil Wright (Sheffield, UK)
Thu 25 10:55
Diabetes Symposium 2
Controversies in the management of DKA
Sheffield Children's NHS Foundation Trust, Sheffield, UK
Thu 25 11:15
Diabetes Symposium 2
Type 1 diabetes: moving into adulthood
Portsmouth Hospital, Portsmouth, UK
Thu 25 11:35
Diabetes Symposium 2
Q&A
Thu 25 14:55
Diabetes Symposium 3
Chair: Ritika Kapoor (London, UK) and Chizo Agwu (Birmingham, UK)
Thu 25 14:55
Diabetes Symposium 3
Early detection of neonatal diabetes
Royal Devon and Exeter NHS Foundation Trust, Exeter, UK
Thu 25 15:15
Diabetes Symposium 3
100 years of insulin - is it time for a UK Type 1 diabetes screening strategy?
Oxford, UK
Thu 25 15:35
Diabetes Symposium 3
Q&A
Thu 25 16:55
AGM
Fri 26 09:30
Endocrine Symposium 3
Chair: Lee Martin (London, UK) and Isabelle Sharratt (London, UK)
Fri 26 09:30
Endocrine Symposium 3
Non-medical prescribing: how can you make a difference to your service as a non-medical prescriber?
London South Bank University, London, UK
Fri 26 09:50
Endocrine Symposium 3
Advanced nurse practice: what is advanced nurse practice?
London South Bank University, London, UK
Fri 26 10:10
Endocrine Symposium 3
Running a Paediatric Endocrine Nurse clinic: benefits and tips for success
Alder Hey Children's Hospital, Liverpool, UK
Fri 26 10:30
Endocrine Symposium 3
Q&A
Fri 26 14:00
Endocrine Symposium 4
Chair: Raja Padidela (Manchester, UK) and Renuka Ramakrishnan (Liverpool, UK)
Fri 26 14:00
Endocrine Symposium 4
Interpretation of abnormal thyroid function tests in children and adolescents
Beacon Hospital and University College Dublin, Dublin, Ireland
Fri 26 14:20
Endocrine Symposium 4
Metabolic bone disease of prematurity: recognition, prevention and treatment
Children's Hospital of Philadelphia, Philadelphia, USA
Fri 26 14:40
Endocrine Symposium 4
Newer treatment options for childhood obesity management
University of Minnesota Medical School, Minnesota, USA
Fri 26 15:00
Endocrine Symposium 4
Q&A
Catering and Social 14
Wed 24 10:45
Break
Wed 24 12:55
Lunch
Wed 24 15:25
Break
Thu 25 08:45
Break
Thu 25 10:40
Break
Thu 25 12:25
Break
Thu 25 13:10
Lunch
Thu 25 14:40
Break
Thu 25 15:55
Break
Thu 25 16:40
Break
Fri 26 11:00
Break
Fri 26 12:45
Lunch
Fri 26 13:45
Break
Fri 26 15:30
Break
Nurse 1
Fri 26 09:00
Endocrine Nurses Business Meeting
Other 8
Wed 24 08:50
Welcome and Introduction
Chair: Anitha Kumaran (Southampton, UK)
Wed 24 16:40
CME Officer's Update
Thu 25 09:00
Welcome from BSPED President and Chair
Chairs: Tabitha Randell (Nottingham, UK) & Senthil Senniappan (Liverpool, UK)
Thu 25 14:10
Awards Session - James M Tanner Award
Chair: Tabitha Randell (Nottingham, UK) and Senthil Senniappan (Liverpool, UK)
Thu 25 16:05
Personal Practice Session
Chair: Mehul Dattani (London, UK) and Nikki Davis (Southampton, UK)
Thu 25 16:05
Personal Practice Session
Medical management of T2DM in adolescents
Joslin Diabetes Centre, Boston, USA
Thu 25 16:20
Personal Practice Session
Management of thyroid nodules in children
Philadelphia, USA
Thu 25 16:35
Personal Practice Session
Q&A
Fri 26 12:15
Presentations from Previous Award Winners
Chair: Christina Wei (London, UK) and Jo Blair (Liverpool, UK)
Fri 26 12:15
Presentations from Previous Award Winners
BSPED Research & Innovation Award Winner 2017
Newcastle University, Newcastle upon Tyne, UK
Fri 26 12:23
Presentations from Previous Award Winners
BSPED Research & Innovation Award Winner 2018
Cardiff, UK
Fri 26 12:31
Presentations from Previous Award Winners
BSPED Research & Innovation Award Winner 2018
Queen Mary University of London , London, UK
Fri 26 12:39
Presentations from Previous Award Winners
Q&A
Fri 26 15:45
BSPED 2021 Awards Session
Chair: Sabah Alvi (Leeds, UK) and Helen Storr (London, UK)
Fri 26 16:00
Close of Meeting
Chair: Senthil Senniappan (Liverpool, UK)
Symposium 6
Thu 25 07:45
Industry Sponsored Satellite Symposium
Thu 25 10:55
Endocrine Symposium 1
Chair: Guftar Shaikh (Glasgow, UK) and Senthil Senniappan (Liverpool, UK)
Thu 25 10:55
Endocrine Symposium 1
Fertility preservation in boys
Edinburgh, UK
Thu 25 11:15
Endocrine Symposium 1
Turner syndrome adolescence and beyond
Medical Associates, Belfast, Ireland
Thu 25 11:35
Endocrine Symposium 1
Q&A
Thu 25 14:55
Endocrine Symposium 2
Chair: Gary Butler (London, UK) and Bindu Avatapalle (Cardiff, UK)
Thu 25 14:55
Endocrine Symposium 2
GnRH analogues for gender dysphoria
Amsterdam, The Netherlands
Thu 25 15:15
Endocrine Symposium 2
Using AMH and inhibin B assays in children and young people
London, UK
Thu 25 15:35
Endocrine Symposium 2
Q&A
Fri 26 09:30
Diabetes Symposium 4
Chair: Evelien Gevers (London, UK) and Fiona Campbell (Leeds, UK)
Fri 26 09:30
Diabetes Symposium 4
Optimising time in range using continuous glucose monitoring
University of Leicester, Leicester, UK
Fri 26 09:50
Diabetes Symposium 4
Real world use of the closed loop insulin delivery system
Cambridge, UK
Cambridge, UK
Fri 26 10:10
Diabetes Symposium 4
Personalising insulin therapy using smart pumps, pens and automated insulin delivery systems
Medical University of Graz, Graz, Austria
Fri 26 10:30
Diabetes Symposium 4
Q&A
Fri 26 13:15
Industry Sponsored Expert Insights Session
Fri 26 14:00
Diabetes Symposium 5
Chair: Mars Skae (Manchester, UK) and Nicola Bridges (London, UK)
Fri 26 14:00
Diabetes Symposium 5
Effect of CFTR modulator therapy on cystic fibrosis-related diabetes
University of Oklahoma Health Sciences Center, Oklahoma, USA
Fri 26 14:20
Diabetes Symposium 5
Evaluation and Management of Genetic forms of Obesity
MRC Institute of Metabolic Science, Cambridge, UK
Fri 26 14:40
Diabetes Symposium 5
Psychoeducation and changing behaviour: Knowing how doesn’t always mean action
University College London, London, UK
Fri 26 15:00
Diabetes Symposium 5
Q&A
No Session Type 0

0 result(s) found.

Please wait...

     
      - 
     
     
     


    Abstracts from this event
      Abstracts from other events


          Session starts at:
          Abstract time:
        Event:


        Read full abstract